TABASH, Samir, P. P,BISHOP Charles, W. W,MELNICK, Joel, Z. Z,MESSNER Eric, J. J,PETKOVICH, Martin P. P,WHITE, Jay A. A,埃裏克．,．梅斯納,馬丁．,．佩特科維奇,杰伊．,．懷特,薩米爾.,.塔巴什,查理斯.,.比紹夫,喬爾.,.梅爾尼克,埃裏克.,.梅斯納,馬丁.,.佩特科維奇,杰伊.,.懷特
申请号：
HK16110433.6
公开号：
HK1222132A
申请日:
2016.09.01
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
Methods and compositions for reducing serum parathyroid levels in, for example, chronic kidney disease patients are disclosed. In these methods, an effective amount of a modified release formulation of 25-hydroxy vitamin D is orally administered to a patient suffering from secondary hyperparathyroidism to lower the patient's serum intact parathyroid hormone (iPTH) level, while avoiding a surge in serum total 25-hydroxy vitamin D.
